Obsessive Compulsive Disorder (OCD) — Antibiotic Treatment Trial for the PANDAS/PANS Phenotype
Citation(s)
Allen AJ, Leonard HL, Swedo SE Case study: a new infection-triggered, autoimmune subtype of pediatric OCD and Tourette's syndrome. J Am Acad Child Adolesc Psychiatry. 1995 Mar;34(3):307-11.
Bronze MS, Dale JB Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain. J Immunol. 1993 Sep 1;151(5):2820-8.
Brook I, Dohar JE Management of group A beta-hemolytic streptococcal pharyngotonsillitis in children. J Fam Pract. 2006 Dec;55(12):S1-11; quiz S12. Review.
Brook I A pooled comparison of cefdinir and penicillin in the treatment of group a beta-hemolytic streptococcal pharyngotonsillitis. Clin Ther. 2005 Aug;27(8):1266-73.
Brook I Failure of penicillin to eradicate group A beta-hemolytic streptococci tonsillitis: causes and management. J Otolaryngol. 2001 Dec;30(6):324-9. Review.
Brook I The role of beta-lactamase producing bacteria and bacterial interference in streptococcal tonsillitis. Int J Antimicrob Agents. 2001 Jun;17(6):439-42. Review.
Brook I The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis. 1984 Sep-Oct;6(5):601-7. Review.
Brooks BM, Hart CA, Coleman JW Differential effects of beta-lactams on human IFN-gamma activity. J Antimicrob Chemother. 2005 Dec;56(6):1122-5. Epub 2005 Oct 20.
Brooks BM, Thomas AL, Coleman JW Benzylpenicillin differentially conjugates to IFN-gamma, TNF-alpha, IL-1beta, IL-4 and IL-13 but selectively reduces IFN-gamma activity. Clin Exp Immunol. 2003 Feb;131(2):268-74.
Currie BJ Are the currently recommended doses of benzathine penicillin G adequate for secondary prophylaxis of rheumatic fever? Pediatrics. 1996 Jun;97(6 Pt 2):989-91. Review.
Dajani A, Taubert K, Ferrieri P, Peter G, Shulman S Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics. 1995 Oct;96(4 Pt 1):758-64.
Diggle, P Analysis of longitudinal data. Oxford University Press, 2002.
Faul F, Erdfelder E, Lang AG, Buchner A G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007 May;39(2):175-91.
Gioia GA, Isquith PK, Retzlaff PD, Espy KA Confirmatory factor analysis of the Behavior Rating Inventory of Executive Function (BRIEF) in a clinical sample. Child Neuropsychol. 2002 Dec;8(4):249-57.
Giulino L, Gammon P, Sullivan K, Franklin M, Foa E, Maid R, March JS Is parental report of upper respiratory infection at the onset of obsessive-compulsive disorder suggestive of pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection? J Child Adolesc Psychopharmacol. 2002 Summer;12(2):157-64.
Green B, Shirk S, Hanze D, Wanstrath J The Children's Global Assessment Scale in clinical practice: an empirical evaluation. J Am Acad Child Adolesc Psychiatry. 1994 Oct;33(8):1158-64.
Guilherme L, Kalil J, Cunningham M Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity. 2006 Feb;39(1):31-9. Review.
Guy, W Assessment Manual for Psychopharmacology, rev. edn. Rockville, MD: National Institute of Mental Health, 1976.
Jacobs MR, Johnson CE Macrolide resistance: an increasing concern for treatment failure in children. Pediatr Infect Dis J. 2003 Aug;22(8 Suppl):S131-8. Review.
Kantor L, Hewlett GH, Gnegy ME Enhanced amphetamine- and K+-mediated dopamine release in rat striatum after repeated amphetamine: differential requirements for Ca2+- and calmodulin-dependent phosphorylation and synaptic vesicles. J Neurosci. 1999 May 15;19(10):3801-8.
Kirvan CA, Swedo SE, Kurahara D, Cunningham MW Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea. Autoimmunity. 2006 Feb;39(1):21-9. Review.
Kirvan CA, Swedo SE, Snider LA, Cunningham MW Antibody-mediated neuronal cell signaling in behavior and movement disorders. J Neuroimmunol. 2006 Oct;179(1-2):173-9. Epub 2006 Jul 27.
Kurlan R, Kaplan EL The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive-compulsive symptoms: hypothesis or entity? Practical considerations for the clinician. Pediatrics. 2004 Apr;113(4):883-6.
Kushner HI, Kiessling LS The controversy over the classification of Gilles de la Tourette's syndrome, 1800-1995. Perspect Biol Med. 1996 Spring;39(3):409-35.
Landgraf, J M., Abetz, L., & Ware, J. E. The CHQ user's manual. Boston: The Health Institute, New England Medical Center, 1996.
Mell LK, Davis RL, Owens D Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorder. Pediatrics. 2005 Jul;116(1):56-60.
Meyers, J , & Meyers, K. Rey Complex Figure Test and recognition trial: Professional manual. Psychological Assessment Resources, 1995.
MILLER JM, STANCER SL, MASSELL BF A controlled study of beta hemolytic streptococcal infection in rheumatic families. II. Penicillin prophylaxis among rheumatic fever subjects, comparing different regimens. Am J Med. 1958 Dec;25(6):845-56.
Mineur YS, Picciotto MR, Sanacora G Antidepressant-like effects of ceftriaxone in male C57BL/6J mice. Biol Psychiatry. 2007 Jan 15;61(2):250-2. Epub 2006 Jul 24.
Morikawa K, Torii I, Morikawa S Modulation of IgD and CD20 by ligation of CD5 on tonsillar B cells. Scand J Immunol. 2002 Jan;55(1):44-52.
Murphy ML, Pichichero ME Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS). Arch Pediatr Adolesc Med. 2002 Apr;156(4):356-61.
Murphy, T K., Storch, E. A., & Strawser, M. S. Case Report: Selective Serotonin Reuptake Inhibitor-Induced Behavioral Activation in the PANDAS Subtype. [case report]. Primary Psychiatry, 13(8), 87-89, 2006.
Piacentini J, Bergman RL, Keller M, McCracken J Functional impairment in children and adolescents with obsessive-compulsive disorder. J Child Adolesc Psychopharmacol. 2003;13 Suppl 1:S61-9.
Piacentini, J C., & Jaffer, M. P., J. C., & Jaffer, M. Measuring functional impairment in youngsters with OCD: Manual for the Child OCD Impact Scale (COIS). Los Angeles, UCLA Department of Psychiatry, 1999.
Pichichero ME, Gooch WM 3rd Comparison of cefdinir and penicillin V in the treatment of pediatric streptococcal tonsillopharyngitis. Pediatr Infect Dis J. 2000 Dec;19(12 Suppl):S171-3.
Pittenger C, Krystal JH, Coric V Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder. NeuroRx. 2006 Jan;3(1):69-81. Review.
PRECHTL HF, STEMMER J The choreiform syndrome in children. Dev Med Child Neurol. 1962 Apr;4:119-27.
Rentz AM, Matza LS, Secnik K, Swensen A, Revicki DA Psychometric validation of the child health questionnaire (CHQ) in a sample of children and adolescents with attention-deficit/hyperactivity disorder. Qual Life Res. 2005 Apr;14(3):719-34.
Sorensen JL, Hargreaves WA, Friedlander S Child global rating scales: selecting a measure of client functioning in a large mental health system. Eval Program Plann. 1982;5(4):337-47.
Wood, H F., Feinstein, A. R., Taranta, A., & Simpson, R. Rheumatic fever in children and adolescents III. Comparative effectiveness of three prophylaxis regimens in preventing streptococcal infections and rheumatic fever. Annuals of Internal Medicine, 60(supplement 5), 31-46, 1964.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.